NATCOPHARM Intraday Analysis...

NATCOPHARM Share Price

Open 919.90 Change Price %
High 919.90 1 Day -11.45 -1.26
Low 881.95 1 Week -49.75 -5.24
Close 899.95 1 Month -32.35 -3.47
Volume 281117 1 Year 443.75 97.27
52 Week High 1015.95
52 Week Low 442.80
NATCOPHARM Important Levels
Resistance 2 935.13
Resistance 1 920.63
Pivot 900.60
Support 1 879.27
Support 2 864.77
NSE INDIA Most Active Stocks
SUZLON 19.75 -3.19%
JPASSOCIAT 10.25 -10.09%
JINDALSTEL 108.15 -4.92%
SOUTHBANK 25.60 -0.58%
GMRINFRA 15.90 -5.36%
HDIL 82.95 -7.21%
ICICIBANK 306.05 0.72%
RCOM 28.00 -6.04%
BANKINDIA 146.45 -7.60%
SINTEX 104.60 -7.31%
More..
NSE INDIA Top Gainers Stocks
KESARENT 84.00 20.00%
AUSTRAL 0.30 20.00%
XLENERGY 2.75 19.57%
MIRCELECTR 14.45 10.31%
SAMTEL 0.55 10.00%
INDOSOLAR 9.95 9.34%
XCHANGING 53.95 8.77%
MTEDUCARE 68.20 8.51%
MAXVIL 93.65 7.71%
ELECTHERM 198.15 6.79%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
KSERASERA 0.10 -33.33%
LCCINFOTEC 0.20 -20.00%
FCSSOFT 0.20 -20.00%
VIDEOIND 65.60 -19.95%
VALUEIND 8.85 -19.55%
KCP 111.90 -15.55%
KMSUGAR 19.80 -15.02%
DPL 83.20 -13.29%
PSL 4.55 -12.50%
More..

Natco Pharma Limited (NSE: NATCOPHARM)

NATCOPHARM Technical Analysis 4
As on 23rd May 2017 NATCOPHARM Share Price closed @ 899.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 683.09 & Buy for SHORT-TERM with Stoploss of 865.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
NATCOPHARM Target for May
1st Target up-side 1018.97
2nd Target up-side 1085.57
3rd Target up-side 1152.17
1st Target down-side 828.93
2nd Target down-side 762.33
3rd Target down-side 695.73
NATCOPHARM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 47.80 Sideways
MFI (14) MFI is 58.52 Sideways
CCI (20) CCI is -94.91 Sideways
WILLIAM %R (14) William %R is -79.08 Sideways
ADX (14) ADX is 18.33 Range Bound
PSAR Stoploss For Short Sell 968.00
10 Day Avg Volume Traded 7.74 % More then 10 Day Average Volume
NATCOPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NATCOPHARM Address
NATCOPHARM
N/A
NATCOPHARM Latest News
Natco Pharma - Natco receives Generic Sofosbuvir (Sovaldi) approval for India   Moneycontrol.com   - 12th Mar 15
NATCO Pharma stock rises most on US court ruling   Business Today   - 11th Mar 15
Buy Natco Pharma; target of Rs 1920: ICICIdirect   Moneycontrol.com   - 11th Mar 15
UPDATE 1-India's Natco Pharma ties up with Gilead on hepatitis C drugs   Reuters   - 02nd Mar 15
Natco Pharma - Q3 results on Feb 11, 2015   Moneycontrol.com   - 30th Jan 15
Natco Pharma dips on preferential share allotment at discount   Business Standard   - 17th Dec 14
Natco Pharma CFO passes away   Hindu Business Line   - 23rd Oct 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir.)   JD Supra (press release)   - 25th Jul 14
Gilead Sciences, Inc. v. Natco Pharma Limited   Lexology (registration)   - 08th May 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)   Patent Docs   - 29th Apr 14
Interactive Technical Analysis Chart Natco Pharma Limited ( NATCOPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Natco Pharma Limited
NATCOPHARM Business Profile
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,439.26 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director. It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.